This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Shin, Y. C. Articles by Jung, J. U. PubMed PubMed Citation Articles by Shin, Y. C. Articles by Jung, J. U.

Kaposi's Sarcoma–Associated Herpesvirus Viral IFN Regulatory Factor 3 Stabilizes Hypoxia-Inducible Factor-1 to Induce Vascular Endothelial Growth Factor Expression

¹ Department of Microbiology and Molecular Genetics and Tumor Virology Division, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts and ² Department of Microbiology, University of Ulsan College of Medicine, Seoul, Korea

Requests for reprints: Young C. Shin, Tumor Virology Division, New England Primate Research Center, Harvard Medical School, 1 Pine Hill Drive, Southborough, MA 01772. Phone: 508-786-1472; Fax: 508-786-1416; E-mail: young_shin{at}hms.harvard.edu.

Key Words: KSHV • vIRF3 • HIF-1 • stabilization • VEGF

Kaposi's sarcoma–associated herpesvirus (KSHV) is the etiologic agent associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Hypoxia-inducible factor-1 (HIF-1) is the master regulator of both developmental and pathologic angiogenesis, composed of an oxygen-sensitive -subunit and a constitutively expressed β-subunit. HIF-1 activity in tumors depends on the availability of the HIF-1 subunit, the levels of which are increased under hypoxic conditions. Recent studies have shown that HIF-1 plays an important role in KSHV reactivation from latency and pathogenesis. Here, we report a novel mechanism by which KSHV activates HIF-1 activity. Specific interaction between KSHV viral IFN regulatory factor 3 (vIRF3) and the HIF-1 subunit led to the HIF-1 stabilization and transcriptional activation, which induced vascular endothelial growth factor expression and ultimately facilitated endothelial tube formation. Remarkably, the central domain of vIRF3, containing double -helix motifs, was sufficient not only for binding to HIF-1 but also for blocking its degradation in normoxic conditions. This indicates that KSHV has developed a unique mechanism to enhance HIF-1 protein stability and transcriptional activity by incorporating a viral homologue of cellular IRF gene into its genome, which may contribute to viral pathogenesis. [Cancer Res 2008;68(6):1751–9]